| Revenue Growth | Total revenue $19M, up 35%; FTIR 55% of revenue; international 40%. |
|---|---|
| Mgmt Confidence | High confidence in 2027 drivers: Near-Lab, Next-Gen MX-908, and AvCAD. |
| Demand Visibility | Strong pipeline; 300+ devices shipped in Q3; 4,400 total install base. |
| Order Book | $6M protector order from Asia-Pacific; $2M framework agreement in Europe. |
| Margin Trends | Adjusted gross margin 58%; full year expected mid-to-high 50% range. |
| Op. Leverage | Adjusted EBITDA loss $1.7M; on track for mid-single digit million loss. |
| Pricing Power | Near-Lab subscriptions priced at 50% of device cost annually. |
| Vol vs Price | Volume-led growth with record 300+ devices shipped in the quarter. |
| Segment Growth | Handheld product/service revenue up 35%; OEM/Funded partnerships up 42%. |
| New Clients | 100 Near-Lab devices sold; half to customers new to 908 Devices. |
| Capex & Debt | Ended quarter with $99.1M cash and no debt outstanding. |
| Regulatory | Monitoring DEA/FDA synthetic opioid controls; AvCAD testing with US Army. |
| Commentary | Focus on 'connected services' vision to build recurring revenue durability. |
| New Launches | Next-generation MX-908 shipping to early access customers by year-end. |
Growth
Revenue hit $19M, up 35% YoY; international revenue doubled to 40% of total.
Outlook
Full year 2026 revenue guided to $68.5M-$70M, representing 22-25% growth.
Risks
State and local revenue fell 20% YoY; mass spec service revenue declined.
The company's earnings call, NASDAQ: MASS, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
908 Devices Inc.: key numbers
- Share price
- $9.19Close, Nov 16
- Market cap
- $382M
- Shares outstanding
- 41.58MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Laboratory Analytical InstrumentsSIC 3826
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from 908 Devices Inc.
All →908 Devices Q3 2026 Results: Net Loss of $4.58M, Loss Narrows
908 Devices Inc. reported total revenue of $18.95 million for the third quarter of 2026, a 35% increase year-over-year. Despite the revenue growth, the company recorded a net loss of $4.58 million for the quarter, though this was a significant improvement from the $14.98 million net loss in the prior year period.
- Key figure
- Net loss $4.58M
908 Devices Financial Results
908 Devices reported record third-quarter revenue of $19.0 million, a 35% increase year-over-year, driven by strong demand for its FTIR portfolio and the addition of NIRLab revenue. The company achieved a record 308 device shipments in the quarter and raised the low end of its full-year 2026 revenue guidance to a range of $68.5 million to $70.0 million.
- Term
- Q3 2026
“We had a strong third quarter, driven by our FTIR portfolio, with revenue growing 35% year-over-year to $19 million and device shipments reaching a new company record.”
Kevin J. Knopp, CEO and Co-founder
“Our proven platforms are winning orders across the globe as customers accelerate efforts to modernize their detection capabilities and stay ahead of an evolving threat landscape.”
Kevin J. Knopp, CEO and Co-founder
908 Devices Director Christopher D. Brown Sells $328K of Stock
Christopher D. Brown, Director, sold 30,000 shares of 908 Devices Inc. at $10.95 a share, worth $328K in total on Nov 4, 2026. Shares held after the trade: 775,559 (-3.7%).
- Value
- $328K
- Shares
- 30,000
- Price
- $10.95
- Role
- Director
- Holding change
- -3.7%
- Trade date
- Nov 4, 2026
908 Devices Director Christopher D. Brown Sells $357K of Stock
Christopher D. Brown, Director, sold 30,000 shares of 908 Devices Inc. at $11.89 a share, worth $357K in total on Oct 7, 2026. Shares held after the trade: 745,559 (-3.9%).
- Value
- $357K
- Shares
- 30,000
- Price
- $11.89
- Role
- Director
- Holding change
- -3.9%
- Trade date
- Oct 7, 2026
908 Devices CFO Joseph H. Griffith IV Sells $65.2K of Stock
Joseph H. Griffith IV, CFO, sold 5,000 shares of 908 Devices Inc. at $13.03 a share, worth $65.2K in total on Oct 6, 2026. Shares held after the trade: 116,497 (-4.1%).
- Value
- $65.2K
- Shares
- 5,000
- Price
- $13.03
- Role
- CFO
- Holding change
- -4.1%
- Trade date
- Oct 6, 2026
908 Devices Insider AWM Investment Company Inc. Sells $207K of Stock
AWM Investment Company Inc. sold 18,000 shares of 908 Devices Inc. at $11.52 a share, worth $207K in total on Sep 29, 2026. Shares held after the trade: 4,736,773 (-0.4%).
- Value
- $207K
- Shares
- 18,000
- Price
- $11.52
- Holding change
- -0.4%
- Trade date
- Sep 29, 2026